Journal of Perinatology

TABLE 2

FROM:

The Value of Ureaplasma urealyticum Tracheal Culture and Treatment in Premature Infants Following an Acute Respiratory Deterioration

Maroun J Mhanna, Laura J Delong and Hany F Aziz

BACK TO ARTICLE

Table 2. Patients With Positive Uu Cultures

 Presence of CLD* (n=38)Absence of CLD* (n=9)Odds ratio (95% CI) p-Value
GA<28 weeks31/38 (81.57)5/9 (55.55)3.54 (0.75–16.68)0.10
Gender (% male)20/38 (52.63)6/9 (66.66)0.55 (0.12–2.55)0.45
Race (% white)14/38 (36.84)1/9 (11.11)4.66 (0.52–41.31)0.14
BWless than or equal to750 g26/38 (68.42)4/9 (44.44)2.70 (0.61–11.92)0.18
PROM (%)4/38 (10.52)0/9 (0)2.47 (0.12–50.21)0.31
Sepsis (%)6/38 (15.78)1/9 (11.1)1.50 (0.15–14.29)0.72
Erythromycin31/38 (81.57)7/9 (77.77)1.26 (0.21–7.44)0.79
PDA (%)20/38 (52.63)4/9 (44.44)1.38 (0.32–5.98)0.66
Ventilationgreater than or equal to30 days (%)29/38 (76.31)2/9 (22.22)11.27 (1.97–64.27)<0.01
Postnatal steroids (%)33/38 (86.84)3/9 (33.33)13.2 (2.47–70.46)<0.01
NICU§ staygreater than or equal to60 days (%)24/38 (63.15)3/9 (33.33)3.42 (0.73–15.90)0.10

* CLD: chronic lung disease;

 PROM: premature rupture of membranes;

 PDA: patent ductus arteriosus;

§ NICU: neonatal intensive care unit.

BACK TO ARTICLE